In addition, transcription factors, such as mitogen-activated protein kinase kinase-4 (MKK4), transforming growth factor beta (TGF-β), and the polycomb group (PcG) protein BMI1, were reported to suppress PTEN expression in several cancer models (45–48). The gene discussed is MAP2K4; the disease is cancer.